Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Sci. Signal., 27 March 2012
Vol. 5, Issue 217, p. ra24
Insight into the Obesity and Cancer Connection
The activity of the mammalian target of rapamycin (mTOR) complex 1 (mTORC1) increases in response to nutrients. Using mice with increased mTORC1 signaling in the liver due to a liver-specific deficiency in an inhibitory component of the mTORC1 pathway, Menon et al. found that these mice spontaneously developed hepatocellular carcinoma, a frequently occurring and aggressive form of liver cancer that has few treatment options. Treating these mice with a pharmacological inhibitor of mTORC1 (rapamycin) before the appearance of tumors blocked the development of hepatocellular carcinoma, as well as the pathological changes that preceded tumor formation. mTORC1 signaling increases during obesity, a major risk factor for liver cancer; therefore, these results suggest a role for mTORC1 in linking environmental factors such as diet to the risk of developing certain types of cancers.
Citation: S. Menon, J. L. Yecies, H. H. Zhang, J. J. Howell, J. Nicholatos, E. Harputlugil, R. T. Bronson, D. J. Kwiatkowski, B. D. Manning, Chronic Activation of mTOR Complex 1 Is Sufficient to Cause Hepatocellular Carcinoma in Mice. Sci. Signal.5, ra24 (2012).